With medicine technology development, Immunotherapy has gained great
achievement on treating Polycystic Kidney Disease (PKD). Polycystic Kidney is a
kind of genetic disease, following the regulation of autosomal dominant
inheritance. Both male and female have equal incidence. In the early stage, when
cysts are still small, seldom obvious symptoms can be found. But with cysts
growing and increasing, they will compress surrounding healthy tissue greatly.
Then symptoms appear. Waist pain usually happens firstly, and Haematuria or
Nephropyelitis may appear occasionally. But most patients usually neglect these
symptoms because these symptoms are usually not serious. When cysts replace more
and more renal tissue and pressure become larger and larger, End Stage Renal
Failure happens.
Immunotherapy are transfused into patients' body through vein. After
Immunotherapy entering into kidney lesions, they can differentiate into
necessary cells that tissues need and repair injured renal inherent cells.
Basically, Immunotherapy treat Polycystic Kidney Disease starting with shrinking
cysts in order to reduce pressure on surrounding tissue and recover injured
tissue function, trying to get maximum effect with minimum damage. Eliminating
or controlling cysts in early stage can prevent Polycystic Kidney Disease
developing into Renal Insufficiency and Renal Failure, or even Uremia
greatly.
Besides, by applying Immunotherapy to treat Polycystic Kidney Disease, after
healing, this disease seldom relapses. What's more, Immunotherapy has no side
effect. So it brings no damage to patients' body. Polycystic Kidney Disease
patients should take active treatment before renal function decline with
principle of early finding and early treatment.
